跳到主要导航 跳到搜索 跳到主要内容

Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro

  • Wenqi Li
  • , Jinjin Yu
  • , Xin Xiao
  • , Lulu Zang
  • , Yajie Yang
  • , Jiabao Yu
  • , Qiuxia Huang
  • , Xiaofeng Niu
  • , Weifeng Li
  • Xi'an Jiaotong University
  • Shaanxi Administration of Traditional Chinese Medicine

科研成果: 期刊稿件文章同行评审

13 引用 (Scopus)

摘要

Inflammation plays an important role in the process of atherosclerosis (AS). Inhibition of inflammation is an effective way to prevent AS. Imperatorin (IMP) is a kind of furan coumarin with various activities. In this study, the anti-inflammatory effect of IMP was explored in oxidized low-density lipoprotein (ox-LDL)-induced VSMCs and high fat diet (HFD)-induced ApoE-/- mice. The results showed that IMP attenuated the elevation of TNF-α, IL-6, MCP-1 and NO induced by ox-LDL in supernatant of VSMCs. IMP has normalized the levels of serum lipids (TC, TG, LDL-C and HDL-C) and attenuated inflammatory cytokines in serum. IMP also improved pathological changes and lipid accumulation in aorta. Matrix metalloproteinase-2 (MMP-2) expression in aorta was down-regulated by IMP. IMP could inhibit the phosphorylation of MAPKs pathway in the aorta and VSMCs, resulting in a significant decrease in the contents of p-ERK 1/2, p-JNK and p-P38. Overall, IMP could exert anti-inflammatory effects in vivo and in vitro to interfere with AS.

源语言英语
文章编号107170
期刊International Immunopharmacology
90
DOI
出版状态已出版 - 1月 2021

学术指纹

探究 'Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro' 的科研主题。它们共同构成独一无二的指纹。

引用此